|
Statins may exert influence on prostate cancer growth by reducing inflammation 04/26/2009
|
Cholesterol-lowering drugs called statins may reduce inflammation in prostate tumors, possibly hindering cancer growth, according to a study led by investigators in the Duke Prostate Center.
|
Explosion in drug websites puts patients at risk 04/25/2009
|
Hundreds of websites, many based in Britain, are selling dangerous drugs which should only be prescribed by doctors, an investigation has revealed.
|
MRI: Effective tool for determining pathologic stage of prostate cancer 04/23/2009
|
In patients with prostate cancer undergoing prostatectomy, MR imaging plays an important role in determining if the cancer is restricted to the prostate gland or if it has spread beyond the capsule, according to a study performed at the University of C
|
Vasectomy: What to Expect 04/21/2009
|
You’ll be shocked at the very sound of the words as the request echoes inside your head: “I would like you to cut through my scrotum and disconnect my testicles.” What would possess you to ask such a thing of your doctor?
|
Erectile Dysfunction Treatments Do Not Appear To Damage Vision Over Six Months 04/19/2009
|
Two medications used to treat erectile dysfunction in men (tadalafil and sildenafil) do not appear to have visual side effects when taken daily for six months
|
Male impotence drugs may deserve a second look in women 04/17/2009
|
New studies indicate the three drugs used to treat male impotence also appear to work in females, albeit a little differently, and should give the scientific community pause to take a second look at their potential in the 40 percent of women who report
|
Male sex dysfunction drugs show promise in the lab for treating female sexual disorders 04/17/2009
|
One needs only turn on the television to understand that significant advances have been made in the cure and treatment of male sexual dysfunction. Less visible progress has been made in understanding and treating female sexual disorders
|
Men Looking For Staying Power 04/16/2009
|
|
EAU position statement on screening for prostate cancer 04/16/2009
|
The European Association of Urology (EAU) has taken into consideration the recent scientific information on randomised screening studies on prostate cancer (Schröder et al, NEJM 2009). Based on the results of the European Randomised Study for Scre
|
Study: No Vision Loss From ED Drugs 04/13/2009
|
Researchers say concerns have been raised about possible vision-related side effects associated with regular use of ED drugs. But their study showed no higher rates of vision loss or other eye complications among men who took Viagra or Cialis daily for
|
Erectile dysfunction treatments do not appear to damage vision over 6 months 04/13/2009
|
Two medications used to treat erectile dysfunction in men (tadalafil and sildenafil) do not appear to have visual side effects when taken daily for six months, despite concerns about eye-related complications, according to a report in the April issue o
|
New drug shows promise in treating drug-resistant prostate cancer 04/09/2009
|
A new therapy for metastatic prostate cancer has shown considerable promise in early clinical trials involving patients whose disease has become resistant to current drugs.
|
Gene fusion discovery may lead to improved prostate cancer test 04/09/2009
|
Weill Cornell Medical College study identifies novel type of gene fusion that may be common cancer mechanism
|
Drug shows activity in men with advanced prostate cancer 04/08/2009
|
A new multi-center study shows that an experimental drug lowers prostate specific antigen (PSA) levels – a marker for tumor growth – in men with advanced prostate cancer for whom traditional treatment options have failed. The study, led by
|
A potential new target for treatment of hormone refractory prostate cancer 04/06/2009
|
A new study identifies a protein that modifies the androgen receptor (AR) and influences its ability to regulate target genes linked with the progression of prostate cancer. The research, published by Cell Press in the April 7th issue of the journal Earlier this month, Fox Chase Cancer Center became the first hospital in North America to offer an MRI guided biopsy to detect prostate cancer using Invivo Equipment in a clinical hospital setting. Pioneering new techniques for MRI-guided prostate inte All men over the age of 50 could be tested for prostate cancer after the largest international study ever conducted suggested that screening could save thousands of lives a year in Britain. All men over the age of 50 could be tested for prostate cancer after the largest international study ever conducted suggested that screening could save thousands of lives a year in Britain. EAU press conference: Prostate cancer screening saves lives Screening for prostate cancer can reduce deaths by 20%, according to the results of the European Randomized Study of Screening for Prostate Cancer (ERSPC) published online 1700 hours CET, today 18 March (NEJM, Online First*). ERSPC is the world's large
